Skip to main content
. Author manuscript; available in PMC: 2015 Jun 9.
Published in final edited form as: Drug Dev Ind Pharm. 2011 Dec 10;38(8):995–1007. doi: 10.3109/03639045.2011.637048

Table 4.

Dose response of OG in liposome formulation. Efficacy test against Gonococcus (GC, 5 strains: UPS 1155, UPS 2015, UPS 1170, DOD 633, ATCC 19425, UPS 1137), HSV-1 and HSV-2, HIV-1, and Lactobacillus crispatus (ATCC 6013, 6090, 6027, 2047).

Ratio OG/Lipid % Lipid % OG GC Lactobacillus HSV-1 HSV-2 HIV-1 (% Suppression)
0 10 0 / / − − NA
0.01 10 0.1 / / − − 52
0.03 10 0.3 / / − − 27
0.05 10 0.5 × / + + 80
0.1 10 1.0 × / + + 91
0.3 10 3.0 × × + + 95
0.6 10 6.0 × × + + 99

× = Killing by showing greater than a 4-log drop compared to control after exposure to the formulation mixture for 30 min.

/ = No killing by showing less than a 4-log drop compared to control after exposure to the formulation mixture for 30 min.

+ = Killing by showing greater than a 3-log drop compared to non-treated control.

− = No killing by showing less than a 3-log drop compared to non-treated control.